IDEAYA Biosciences (IDYA) EBIT Margin (2020 - 2026)
IDEAYA Biosciences (IDYA) posted EBIT Margin of -1380.73% for Q2 2026, up 273.91 percentage points from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) EBIT Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at IDEAYA Biosciences was -92.66%; for FY2025, it came in at -72.84%, up 4598.23 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +108.06 percentage points (FY2020 to FY2025).
- In prior years, IDEAYA Biosciences' EBIT Margin was -4671.07% in FY2024 (-4096.22 pp), -574.85% in FY2023 (-452.13 pp), -122.72% in FY2022 (+57.19 pp) and -179.91% in FY2021 (+0.99 pp).
- Quarterly EBIT Margin has run from a low of -2059.11% in Q4 2024 to a high of 52.18% in Q3 2025 over five years.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2025, with a gain of 1189.59 percentage points; the weakest was Q4 2024, with a drop of 990.35 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -1654.63% (Q1 2026), -869.53% (Q4 2025) and 52.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | IDEAYA Biosciences | 3.68 Bn | 757.04 Mn | - | -1,380.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,380.73% |
| Mar 31, 2026 | -1,654.63% |
| Dec 31, 2025 | -869.53% |
| Sep 30, 2025 | 52.18% |
| Dec 31, 2024 | -2,059.11% |
| Dec 31, 2023 | -1,068.77% |
| Sep 30, 2023 | -417.09% |
| Jun 30, 2023 | -922.94% |
| Mar 31, 2023 | -333.49% |
| Dec 31, 2022 | -657.46% |
| Sep 30, 2022 | 2.22% |
| Jun 30, 2022 | -384.53% |
| Mar 31, 2022 | -125.19% |
| Dec 31, 2021 | -620.16% |
| Sep 30, 2021 | -130.49% |
| Jun 30, 2021 | -126.21% |
| Mar 31, 2021 | -126.05% |
| Dec 31, 2020 | -49.95% |
| Sep 30, 2020 | -55.72% |
API Access
IDEAYA Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();